Randomized controlled trials are needed to close the evidence gap in the prevention of preterm birth
Prematurity (<37 weeks gestation) is among the major determinants of infant morbidity and mortality (1). Within developing countries, where the condition is of major public health importance, incidence is around 19% versus 5–7% in developed nations (2). The global estimation of preterm delivery i...
Main Authors: | Emma Kwegyir-Afful, Sharea Ijaz, Kimmo Räsänen, Jos Verbeek |
---|---|
Format: | Article |
Language: | English |
Published: |
Nordic Association of Occupational Safety and Health (NOROSH)
2014-01-01
|
Series: | Scandinavian Journal of Work, Environment & Health |
Subjects: | |
Online Access: |
https://www.sjweh.fi/show_abstract.php?abstract_id=3396
|
Similar Items
-
Prevalence and factors associated with preterm birth at kenyatta national hospital
by: Peter Wagura, et al.
Published: (2018-04-01) -
Maternal serum vitamin D and spontaneous preterm birth
by: A. Kalok, et al.
Published: (2020-02-01) -
Maternal Infection and Preterm Birth: From Molecular Basis to Clinical Implications
by: George Daskalakis, et al.
Published: (2023-05-01) -
Late Preterm birth and its morbidity
by: Salcedo-Ramos Francisco, et al.
Published: (2013-06-01) -
Human papillomavirus infection and associated risk of preterm birth
by: Simona Daniela Savu (Popescu), et al.
Published: (2022-06-01)